Nicole Williams, MD
College of Medicine
As a member of the Translational Therapeutics Program at the OSUCCC – James, Nicole Williams, MD, focuses her research on treating breast cancer and brain metastases from breast cancer. She is also involved in clinical trials investigating new treatments for breast cancer in the neoadjuvant, adjuvant and metastatic settings.
One study looks at how well fulvestrant and palbociclib work in treating older patients with breast cancer that responds to hormone treatment but cannot be removed by surgery. Since estrogen can cause the growth of estrogen-receptor-positive breast cancer cells, hormone therapy using fulvestrant may fight estrogen-receptor-positive breast cancer by blocking the use of estrogen by tumor cells, while palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. As a result, giving fulvestrant together with palbociclib may be an effective treatment for hormone-responsive breast cancer.
Dr. Williams has co-authored numerous articles in peer-reviewed publications such as the International Journal of Behavioral Medicine, Breast Cancer Research and Treatment and the International Journal of Cancer.
Medical Degree, Northeast Ohio Medical University
Rootstown, OH (USA)